kpcczКомплексные проблемы сердечно-сосудистых заболеванийComplex Issues of Cardiovascular Diseases2306-12782587-9537Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”10.17802/2306-1278-2013-1-5-9kpccz-1Research ArticleСтатьиСОВРЕМЕННОЕ СОСТОЯНИЕ РЕНТГЕНЭНДОВАСКУЛЯРНОГО ЛЕЧЕНИЯ ОСТРОГО КОРОНАРНОГО СИНДРОМА И ПЕРСПЕКТИВЫ ЕГО РАЗВИТИЯ В РОССИЙСКОЙ ФЕДЕРАЦИИTHE CURRENT SITUATION AND FUTURE OF THE PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROM IN RUSSIAN FEDERATIONАлекянБ. Г.AlekyanB. G.АбросимовА. В.AbrosimovA. V.Научный центр сердечно-сосудистой хирургии им. А. Н. Бакулева Российской академии медицинских наук, МоскваРоссияBakoulev Scientifi c Center for Cardiovascular Surgery of the Russian Academy of Medical Sciences, MoscowRussian Federation2013260620150159Copyright © Алекян Б.Г., Абросимов А.В., 20152015Алекян Б.Г., Абросимов А.В.Alekyan B.G., Abrosimov A.V.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.nii-kpssz.com/jour/article/view/1

Количество пациентов с острым коронарным синдромом (ОКС), госпитализированных в клиники Российской Федерации в 2011 году, составило 581 182 человека. Из них 195 592 – с острым инфарктом миокарда (ОИМ) и 385 590 – с нестабильной стенокардией. При этом только лишь 4,3 % больных с ОКС и 8,8 % больных с ОИМ получили специализированную помощь – чрескожное коронарное вмешательство (ЧКВ). В 2011 году из 62 329 ЧКВ, проведенных в Российской Федерации, только 24 931 (40 %) было выполнено по поводу ОКС. Целью оказания медицинской помощи больным ОКС в Российской Федерации должны быть: круглосуточная работа ЧКВ-центров; сокращение времени «первый медицинский контакт – баллон»; число первичных ЧКВ должно составлять более 70 % всех случаев инфаркта миокарда с подъемом сегмента ST (ИМпST); каждый больной ИМпST после тромболитической терапии должен быть переведен в ЧКВ-центр в течение 24 часов.

The annual incidence of hospital admission for acute coronary syndrome (ACS) was 581 182 patients in Russian Federation in 2011. There are 195 592 with an acute myocardial infarction (AMI) and 385 590 – with unstable angina. Percutaneous coronary intervention (PCI) were performed for only 4,3 % ACS and 8,8 % AMI patients. There were 62 329 PCIs in the Russian Federation in 2011, and only 24 931 (40 %) were performed for ACS. The Russian Federation goals for ACS treatment were defi ned as follow: existing PCI centres should offer a 24/7 service; short «fi rst medical contact – balloon time» for myocardial infarction with elevation ST STEMI patients; the number of primary PCI should be more than 70 % of all STEMI cases; each STEMI patient after thrombolytic therapy should be transferred to a PCI center during 24 hours.

инфаркт миокарда с элевацией сегмента STчрескожное коронарное вмешательствоSTEMIpercutaneous coronary interventionReferencesБокерия Л. А., Алекян Б. Г. Рентегенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации. М.: НЦССХ им. А. Н. Бакулева РАМН, 2012. 148 с.Бокерия Л. А., Алекян Б. Г. Рентегенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации. М.: НЦССХ им. А. Н. Бакулева РАМН, 2012. 148 с.Чазов Е. И., Руда М. Я. Кардиология. 1987. № 2. C. 5–12.Чазов Е. И., Руда М. Я. Кардиология. 1987. № 2. C. 5–12.Чазов Е. И. Пути повышения эффективности лечения больных ИБС // Тер. архив. 1997. № 9. С. 5–10.Чазов Е. И. Пути повышения эффективности лечения больных ИБС // Тер. архив. 1997. № 9. С. 5–10.American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal defi nition of myocardial infarction classifi cation system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial / M. P. Bonaca [et al.] // Circulation. 2012. Vol. 31 (125(4). P. 577–583.American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal defi nition of myocardial infarction classifi cation system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial / M. P. Bonaca [et al.] // Circulation. 2012. Vol. 31 (125(4). P. 577–583.Antoniucci D. [et al.] // Am. J. Cardiol. 2001. № 88, suppl. 15A.Antoniucci D. [et al.] // Am. J. Cardiol. 2001. № 88, suppl. 15A.Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. 4th ed. Philadelphia: WB Saunders, 1992.Braunwald E. Heart Disease: A Textbook of Cardiovascular Medicine. 4th ed. Philadelphia: WB Saunders, 1992.Clinical and angiographic outcome following implantation of the new less shortening Wallstent in aortocoronary vein grafts: introduction of a second generation stent in the clinical arena / D. Keane [et al.] // J. Intervent. Cardiol. 1994. Vol. 7. P. 557–564.Clinical and angiographic outcome following implantation of the new less shortening Wallstent in aortocoronary vein grafts: introduction of a second generation stent in the clinical arena / D. Keane [et al.] // J. Intervent. Cardiol. 1994. Vol. 7. P. 557–564.Drug-eluting vs bare metal stents in primary angioplasty / G. De Luca [et al.] // Arch. Intern. Med. 2012. Vol. 172. P. 611–621.Drug-eluting vs bare metal stents in primary angioplasty / G. De Luca [et al.] // Arch. Intern. Med. 2012. Vol. 172. P. 611–621.For the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of primary angioplasty with thrombolytic therapy for acute myocardial infarction / C. L. Grines [et al.] // N. Engl. J. Med. 1993. Vol. 328. P. 673–679.For the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of primary angioplasty with thrombolytic therapy for acute myocardial infarction / C. L. Grines [et al.] // N. Engl. J. Med. 1993. Vol. 328. P. 673–679.For the STENTIM-2 Investigators. STENTIM-2 hospital outcome: elective Wiktor stent implantation in acute myocardial infarction versus balloon angioplasty [abstract] / L. Maillard [et al.] // Eur. heart J. 1998. Vol. 19. P. 59.For the STENTIM-2 Investigators. STENTIM-2 hospital outcome: elective Wiktor stent implantation in acute myocardial infarction versus balloon angioplasty [abstract] / L. Maillard [et al.] // Eur. heart J. 1998. Vol. 19. P. 59.GRACE – Gianturco-Roubin stent Acute Closure Evaluation: substrate, challenges and design of a randomized trial of bailout management / D. Keane [et al.] // J. Interven. Cardiol. 1994. Vol. 7. P. 333–339.GRACE – Gianturco-Roubin stent Acute Closure Evaluation: substrate, challenges and design of a randomized trial of bailout management / D. Keane [et al.] // J. Interven. Cardiol. 1994. Vol. 7. P. 333–339.Granger C. B., Califf R. M., Topol E. J. Thrombolytic therapy for acute myocardial infarction // A review. Drugs. 1992. Vol. 44(3). P. 293–325.Granger C. B., Califf R. M., Topol E. J. Thrombolytic therapy for acute myocardial infarction // A review. Drugs. 1992. Vol. 44(3). P. 293–325.Grines C. L. Primary angioplasty – the strategy of choice // N. Engl. J. Med. 1996. Vol. 335. P. 1313–1315.Grines C. L. Primary angioplasty – the strategy of choice // N. Engl. J. Med. 1996. Vol. 335. P. 1313–1315.Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONSAMI): fi nal 3-year results from a multicentre, randomised controlled trial / G. W. Stone [et al.] // Lancet. 2011. Vol. 377. P. 2193–2204.Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONSAMI): fi nal 3-year results from a multicentre, randomised controlled trial / G. W. Stone [et al.] // Lancet. 2011. Vol. 377. P. 2193–2204.Intracoronary stent insertion after balloon angioplasty of chronic total occlusions / S. L. Goldberg [et al.] // J. Am. Coll. Cardiol. 1995. Vol. 26. P. 713–719.Intracoronary stent insertion after balloon angioplasty of chronic total occlusions / S. L. Goldberg [et al.] // J. Am. Coll. Cardiol. 1995. Vol. 26. P. 713–719.Keeley E. C., Boura J. A., Grines C. L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials // Lancet. 2003. Vol. 361. P. 13–20.Keeley E. C., Boura J. A., Grines C. L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials // Lancet. 2003. Vol. 361. P. 13–20.Long-term clinical follow-up of patients treated with the self-expanding coronary stent for acute occlusion during balloon angioplasty of the right coronary artery / J. J. Goy [et al.] // J. Am. Coll. Cardiol. 1992. Vol. 19. P. 1593–1596.Long-term clinical follow-up of patients treated with the self-expanding coronary stent for acute occlusion during balloon angioplasty of the right coronary artery / J. J. Goy [et al.] // J. Am. Coll. Cardiol. 1992. Vol. 19. P. 1593–1596.Marco J., Fajadet J. Seven years of coronary stenting: evolution of therapeutics, techniques and results // Beyar R., G. Keren, M. B. Leon, P. W. Serruys (eds). Frontiers in interventional cardiology. London: Martin Dunitz, 1997. P. 83–94.Marco J., Fajadet J. Seven years of coronary stenting: evolution of therapeutics, techniques and results // Beyar R., G. Keren, M. B. Leon, P. W. Serruys (eds). Frontiers in interventional cardiology. London: Martin Dunitz, 1997. P. 83–94.Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction / G. O. Hartzler [et al.] // Am. Heart J. 1983. Vol. 106 (5 Pt 1). P. 965–973.Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction / G. O. Hartzler [et al.] // Am. Heart J. 1983. Vol. 106 (5 Pt 1). P. 965–973.Prevention of restenosis after percutaneous coronary interventions: the medical approach / S. Rosanio [et al.] // Thromb. Haemost. 2005. Vol. 82 (1). P. 164–170.Prevention of restenosis after percutaneous coronary interventions: the medical approach / S. Rosanio [et al.] // Thromb. Haemost. 2005. Vol. 82 (1). P. 164–170.Self expanding stents for the management of aortoostial stenoses in saphenous vein bypass grafts / J. E. Nordrehaug [et al.] // Br. Heart J. 1994. Vol. 72. P. 285–287.Self expanding stents for the management of aortoostial stenoses in saphenous vein bypass grafts / J. E. Nordrehaug [et al.] // Br. Heart J. 1994. Vol. 72. P. 285–287.Serial antiplatelet effects of combined treatment with ticlopidine and aspirine after stent implantation [abstract] / J. P. Preiss [et al.] // Circulation. 1996. Vol. 94. P. 685.Serial antiplatelet effects of combined treatment with ticlopidine and aspirine after stent implantation [abstract] / J. P. Preiss [et al.] // Circulation. 1996. Vol. 94. P. 685.Short- and long-term clinical and quantitative angiographic results with the new less shortening Wallstent for vessel reconstruction in chronic total occlusion: a quantitative angiographic study / Y. Ozaki [et al.] // J. Am. Coll. Cardiol. 1996. Vol. 28. P. 354–360.Short- and long-term clinical and quantitative angiographic results with the new less shortening Wallstent for vessel reconstruction in chronic total occlusion: a quantitative angiographic study / Y. Ozaki [et al.] // J. Am. Coll. Cardiol. 1996. Vol. 28. P. 354–360.Stone G. W. Primary stenting in acute myocardial infarction: the promise and the proof // Circulation. 2004. Vol. 97. P. 2482–2485.Stone G. W. Primary stenting in acute myocardial infarction: the promise and the proof // Circulation. 2004. Vol. 97. P. 2482–2485.Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes / L. Wallentin [et al.] // N. Engl. J. Med. 2009. Vol. 361. P. 1045–1057.Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes / L. Wallentin [et al.] // N. Engl. J. Med. 2009. Vol. 361. P. 1045–1057.Zalewski J., El-Massri N., Klimeczek P. The Predictive Value of Microvascular Obstruction in Determination of Left Venticular Injury and Function after Primary Coronary Angioplasty // Am. J. Cardiol. 2004. Vol. 94 (l 6A). P. 17E.Zalewski J., El-Massri N., Klimeczek P. The Predictive Value of Microvascular Obstruction in Determination of Left Venticular Injury and Function after Primary Coronary Angioplasty // Am. J. Cardiol. 2004. Vol. 94 (l 6A). P. 17E.

The authors declare that there are no conflicts of interest present.